EIB finances modernisation of the Poznań Medical University

EIB finances modernisation of the Poznań Medical University

Add us as your preferred source on Google to see more of our content in Search.

Google logoAdd to Preferred Sources

The European Investment Bank (EIB) has agreed to provide PLN 114.77 million (some EUR 27.3 million) to finance an increase in Poznań Medical University’s capacity to provide education, research, and health services. This transaction is guaranteed by the European Fund for Strategic Investments (EFSI), being the central pillar of the Investment Plan for Europe.

The EFSI support makes it possible to conclude the loan without a guarantee from the Republic of Poland. This is the second EIB loan provided directly to a Polish university. The first, worth PLN 100 million, was signed in April this year with Warsaw Medical University.

The EIB loan will finance the design, construction and equipping of a new state-of-the-art medical simulations centre at the university. The investment also covers the construction of the new site of the Faculty of Pharmacy and its Centre for Innovative Pharmaceutical Technologies containing certified research laboratories. The loan will furthermore enable the extension and rehabilitation of two university hospitals: the emergency ward at Heliodor Święcicki University Hospital and the ophthalmology ward along with the genetic diseases unit at the University Hospital of the Lord’s Transfiguration.

This project benefited from advisory support from the European Investment Advisory Hub, which helped Poznań Medical University to structure the investment and its future revenue generation and accelerated the project’s implementation.

EIB Vice-President Vazil Hudák commented: “This innovative operation supported by the EIB and the Investment Plan for Europe will increase the quality of education and RDI in Poznań, the fifth most populated Polish city. It will improve the provision of healthcare services for citizens, which in Poland is still below the OECD and EU averages in various aspects, such as the long waiting time to seek specialists and one of the lowest ratios of medical professionals per inhabitants.”

European Commissioner for Health and Food Safety Vytenis Andriukaitis said: “As a former cardiac surgeon, I can wholeheartedly understand the importance of research and advancement in medical science to ensure high-quality care and services. I am happy to see that Poznań will greatly benefit in these domains, thanks in part to a loan guarantee from the European Fund for Strategic Investments. Investing in this project is investing in the people of Poland, and Europe”.

Original source: EIB
Published on 28 June 2018